Buffalo Translational Consortium News

UB is awarded $8.2 million NIH grant for Women’s Health Initiative Regional Coordinating Center directed by Dr. Jean Wactawski-Wende

Posted on 12/15/10 at 06:51 pm

UB has received an $8.2 million award from the National Heart, Lung and Blood Institute to administer a new round of studies that extend the Women's Health Initiative (WHI) research for another five years. The initial 40 WHI centers across the U.S. have been grouped into four regional centers to carry out this new initiative. UB will oversee scientific direction and the participant contacts of the Northeast region's nine institutions. Jean Wactawski-Wende, PhD Professor and Associate Chair of Social and Preventive Medicine in the School of Public Health and Health and Health Professions is principal investigator on the new award. Dr. Wactawski-Wende is Co Director of the Buffalo CTRC Clinical Research Center.

UB HIV Clinical Pharmacology Research Program receives $2.3 million NIH training grant directed by Dr. Gene Morse

Posted on 12/10/10 at 02:15 pm

The NIH has awarded $2.3 million to the UB HIV Clinical Pharmacology Research Program housed in the UB School of Pharmacy and Pharmaceutical Sciences and Center of Excellence in Bioinformatics and Life Sciences to host visiting pharmaceutical scientists from resource limited African countries to train them in conducting clinical trials and research on HIV/AIDS.  The HIV Clinical Pharmacology Research Program has received more that $11 million in NIH funding since 2008. The program includes a Pharmacology Quality Assurance (CPQA) program, designed to ensure that HIV/AIDS researchers in resource-limited countries conducted high-quality, pharmacology-focused clinical trials. Gene Morse PharmD, Professor of Pharmacy Practice and Associate Director of the Center for Excellence in Bioinformatics and Life Sciences is principal investigator.  Dr. Morse is also Associate Director of the Institute for Healthcare Informatics and plays a leadership role in the Biomedical Informatics Key Function.

Read more: http://www.buffalo.edu/news/11975

HEALTHeLINK awarded $10 Million Health Information Technology Grant from New York State Department of Health

Posted on 12/08/10 at 01:14 pm

HEALTHeLINK is a BTC community partner institution and the Western New York Clinical Information Exchange that includes clinical data from all 3 BTC healthcare institutions (Great Lakes Health, Roswell Park Cancer Institute and UBMD). HEALTHeLINK has been awarded a $10 million grant from New York State to improve the coordination of health care through the use of health information technology. The grant will support the creation of a clinical information model to enhance population and public health services. HEALTHeLINK participated in the initial design and testing of the public health information exchange model being used across New York State and is thus well positioned to further develop the model to track, monitor, and report on public health information in Western New York. These systems will then be replicated by other regional health information organizations (RHIOs) across the state.

Read more about it on WNY Healthelink.com: http://www.wnyhealthelink.com/

And on BuffaloNews.com: http://www.buffalonews.com/

Hauptman Woodward Institute’s Dr. Michael Malkowski receives $6.7 million NIH Grant to establish Membrane Protein Structural Biology Consortium

Posted on 12/03/10 at 09:51 am

Hauptmann Woodward Institute is a world class facility that specializes in Xray crystallography and molecular structure determination. As a BTC partner, HWI contributes importantly in structural determination of drugs and drug targets.  Dr. Michael G. Malkowski, an HWI senior research scientist, has received a $6.7 million grant from the National Institutes of Health to establish the Membrane Protein Structural Biology Consortium as one of nine centers in the US responsible for determining membrane protein structures within a larger NIH biology-based initiative. This project is designed both to solve structures of medically important membrane proteins and to improve the available technologies for solving such structures.  This initiative contributes importantly to the BTC by enhancing drug development, particularly related to membrane protein targets.

Read more about the Membrane Protein Structural Biology Consortium: http://www.mpsbc.org


Page 32 of 33